Timing Pharmaceutical Co

Timing Pharmaceutical Co ROCE

The Return on Capital Employed (ROCE) of Timing Pharmaceutical Co (6659.TWO) as of Nov 1, 2026 is 4.07 %. In the previous year, Return on Capital Employed (ROCE) was 7.07 % — a change of -42.48% (lower).

ROCE

4.07 %

YoY

-42.48%

Last updated:

In 2024, Timing Pharmaceutical Co's return on capital employed (ROCE) was 4.07 %, a -42.48% increase from the 7.07 % ROCE in the previous year.

The Timing Pharmaceutical Co ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2022
5.68 TWD
Jan 1, 2023
7.07 TWD
Jan 1, 2024
4.07 TWD
The Timing Pharmaceutical Co ROCE history
YEARROCEYoY
4.07 %-42.48%
7.07 %+24.53%
5.68 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Timing Pharmaceutical Co Stock analysis

What does Timing Pharmaceutical Co do? Timing Pharmaceutical Co Ltd generates revenue through manufacturing concentrated Chinese medicine preparations, health foods, and traditional Chinese medicine formulations for domestic and overseas markets. The company accepts applications for licenses and permits related to Chinese medicine, food, and pharmaceutical products, and offers contract manufacturing services. Its comprehensive sales network covers Chinese medicine hospitals and major pharmacies across Taiwan, supported by a professional supply chain and service network. The firm also provides testing services and CDMO services for new pilot projects in research and development. The primary buyers of Timing Pharmaceutical's products include Chinese medicine hospitals, major pharmacies, and overseas markets. Domestic sales are facilitated through a full-fledged professional supply chain and service network, while overseas markets are served through direct exports and partnerships. The company's focus on traditional Chinese medicine and pharmaceuticals drives demand from healthcare institutions and consumers seeking natural health solutions. Timing Pharmaceutical Co Ltd invests annually in research and development for new pilot projects, which are supported by its contract research and development and manufacturing organization (CDMO) services. These services are contracted by clients seeking to develop and manufacture pharmaceutical products, including traditional Chinese medicine formulations. The company's portfolio includes concentrated Chinese medicine preparations, health foods, and traditional Chinese medicine formulations, all of which are distributed through its established network. Timing Pharmaceutical Co is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Timing Pharmaceutical Co's Return on Capital Employed (ROCE)

Timing Pharmaceutical Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Timing Pharmaceutical Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Timing Pharmaceutical Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Timing Pharmaceutical Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Timing Pharmaceutical Co stock

Return on Capital Employed (ROCE) of Timing Pharmaceutical Co is 4.07 % in 2024.

Return on Capital Employed (ROCE) of Timing Pharmaceutical Co changed from 7.07 % to 4.07 %, representing a -42.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Timing Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Timing Pharmaceutical Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Timing Pharmaceutical Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Timing Pharmaceutical Co